高级检索
林玉双, 洪文荣. 黑暗链霉菌tobS1-C基因缺失突变株的构建[J]. 中国药科大学学报, 2012, 43(1): 92-96.
引用本文: 林玉双, 洪文荣. 黑暗链霉菌tobS1-C基因缺失突变株的构建[J]. 中国药科大学学报, 2012, 43(1): 92-96.
LIN Yu-shuang, HONG Wen-rong. Construction of Streptomyces tenebrarius mutant with knockout of tobS1-C genes[J]. Journal of China Pharmaceutical University, 2012, 43(1): 92-96.
Citation: LIN Yu-shuang, HONG Wen-rong. Construction of Streptomyces tenebrarius mutant with knockout of tobS1-C genes[J]. Journal of China Pharmaceutical University, 2012, 43(1): 92-96.

黑暗链霉菌tobS1-C基因缺失突变株的构建

Construction of Streptomyces tenebrarius mutant with knockout of tobS1-C genes

  • 摘要: 通过敲除妥布霉素生物合成基因tobS1-C,定向选育阿泊拉霉素高产菌株。PCR扩增tobS1-C基因上下游同源序列和红霉素抗性基因ermE,构建穿梭载体pSH6,利用接合转移法转化黑暗链霉菌Tt49,经同源重组,敲除tobS1-C两基因序列,共2484 bp,获得框内删除突变株黑暗链霉菌T103(△tobS1-C)。发酵验证表明突变株不再合成妥布霉素,只合成阿泊拉霉素。

     

    Abstract: In order to breed a mutant strain for high production of apramycin,carbamoyltobramycin biosynthesis genes tobS1-C were delected from Streptomyces tenebrarius through homologous recombination.Gene deletion vector pSH6 was constructed and introduced into S.tenebrarius Tt49 through conjugal transfer.tobS1-C genes in the chromosome were displaced by deletion allele on the plasmid via double crossover.Then the mutant S.tenebrarius T103(△tobS1-C)was proved to be genetically stable.Shaking flask experiments and TLC analysis showed that the mutant strain only produced apramycin.

     

/

返回文章
返回